Preliminary evaluation of a structured support program for young people not in education, employment, or training

Feasibility, acceptability, and preliminary efficacy of the Transition program for young people not in education, employment, or training: a pilot randomized controlled trial with a support as usual comparator

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN23352772

Enrollment

Registered

2021-10-08

Start date

2021-11-08

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of life, mental health, self-efficacy and functioning in young people not in education, employment, or training Not Applicable

Interventions

This pilot trial will employ a parallel-groups design, where participants will be randomly assigned (1:1 allocation rate) by permuted block randomisation to either the Transition program as an add-on

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Current participant inclusion criteria as of 29/10/2021: 1. Aged 16 to 20 years 2. Have not completed upper-secondary school and currently not enrolled in education or training 3. Sufficient proficiency in Swedish Previous participant inclusion criteria: 1. Aged 16 to 20 years 2. Have not completed upper-secondary school and currently not enrolled in education or training

Exclusion criteria

Exclusion criteria: 1. Intellectual disability 2. Currently preparing actively for enrolment in education

Design outcomes

Primary

Measure	Time frame
Feasibility/acceptability: 1. Recruitment rate, intervention uptake, and retention is measured using information collected continuously over the course of the trial 2. Characteristics of the included and retained samples (e.g., diagnoses, age, gender, years of schooling) collected at baseline 3. Participant satisfaction and relevance measured using course evaluations after each of the 8 sessions and post-intervention 4. Participation/involvement measured using the Patient Participation and Rehabilitation Questionnaire post-intervention 5. Negative effects measured using the Negative Effects Questionnaire post-intervention, one free text question included in the course evaluations administered after each session and post-intervention, and spontaneously reported events 5. Feasibility/acceptability overall based on in-depth interviews with participants and staff mid-intervention and post-intervention	—

Measure

Time frame

Feasibility/acceptability: 1. Recruitment rate, intervention uptake, and retention is measured using information collected continuously over the course of the trial 2. Characteristics of the included and retained samples (e.g., diagnoses, age, gender, years of schooling) collected at baseline 3. Participant satisfaction and relevance measured using course evaluations after each of the 8 sessions and post-intervention 4. Participation/involvement measured using the Patient Participation and Rehabilitation Questionnaire post-intervention 5. Negative effects measured using the Negative Effects Questionnaire post-intervention, one free text question included in the course evaluations administered after each session and post-intervention, and spontaneously reported events 5. Feasibility/acceptability overall based on in-depth interviews with participants and staff mid-intervention and post-intervention

—

Secondary

Measure	Time frame
Current secondary outcome measures as of 29/10/2021: Preliminary efficacy: 1. Quality of life measured using Assessment of Quality of Life (AQoL-8D) and EQ-5D-5L at baseline, post-intervention, and 6 months after completion 2. Mental health measured using the General Health Questionnaire (GHQ-12) at baseline, post-intervention, and 6 months after completion 3. Self-efficacy measured using the Generalized Self-Efficacy Scale at baseline, post-intervention, and 6 months after completion 4. Functioning measured using the Social and Self-Direction subscales of the Adaptive Behavior Assessment System (ABAS) at baseline, post-intervention, and 6 months after completion 5. Knowledge within the life domains covered by the Transition program measured using a knowledge test developed for this purpose at post-intervention Previous secondary outcome measures: Preliminary efficacy: 1. Quality of life measured using Assessment of Quality of Life (AQoL-8D) and EQ-5D-5L at baseline, post-intervention, and 6 months after completion 2. Mental health measured using the General Health Questionnaire (GHQ-12) at baseline, post-intervention, and 6 months after completion 3. Self-efficacy measured using the Generalized Self-Efficacy Scale at baseline, post-intervention, and 6 months after completion 4. Functioning measured using Adaptive Behavior Assessment System (ABAS) at baseline, post-intervention, and 6 months after completion 5. Knowledge within the life domains covered by the Transition program measured using a knowledge test developed for this purpose at post-intervention	—

Measure

Time frame

Current secondary outcome measures as of 29/10/2021: Preliminary efficacy: 1. Quality of life measured using Assessment of Quality of Life (AQoL-8D) and EQ-5D-5L at baseline, post-intervention, and 6 months after completion 2. Mental health measured using the General Health Questionnaire (GHQ-12) at baseline, post-intervention, and 6 months after completion 3. Self-efficacy measured using the Generalized Self-Efficacy Scale at baseline, post-intervention, and 6 months after completion 4. Functioning measured using the Social and Self-Direction subscales of the Adaptive Behavior Assessment System (ABAS) at baseline, post-intervention, and 6 months after completion 5. Knowledge within the life domains covered by the Transition program measured using a knowledge test developed for this purpose at post-intervention Previous secondary outcome measures: Preliminary efficacy: 1. Quality of life measured using Assessment of Quality of Life (AQoL-8D) and EQ-5D-5L at baseline, post-intervention, and 6 months after completion 2. Mental health measured using the General Health Questionnaire (GHQ-12) at baseline, post-intervention, and 6 months after completion 3. Self-efficacy measured using the Generalized Self-Efficacy Scale at baseline, post-intervention, and 6 months after completion 4. Functioning measured using Adaptive Behavior Assessment System (ABAS) at baseline, post-intervention, and 6 months after completion 5. Knowledge within the life domains covered by the Transition program measured using a knowledge test developed for this purpose at post-intervention

—

Countries

Sweden

Contacts

Public ContactUlf Jonsson

ulf.jonsson@ki.se+46 (0)73 806 43 37

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026